Identifying predictors of HPV ‐related head and neck squamous cell carcinoma progression and survival through patient‐derived models-Reference-Cited by-同舟云学术

Identifying predictors of HPV ‐related head and neck squamous cell carcinoma progression and survival through patient‐derived models

Published:2020-07-06 Issue:11 Volume:147 Page:3236-3249
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Facompre Nicole D.¹,Rajagopalan Pavithra¹,Sahu Varun¹,Pearson Alexander T.²,Montone Kathleen T.³,James Claire D.⁴,Gleber‐Netto Frederico O.⁵,Weinstein Gregory S.¹,Jalaly Jalal³,Lin Alexander⁶,Rustgi Anil K.⁷,Nakagawa Hiroshi⁷,Califano Joseph A.⁸,Pickering Curtis R.⁵,White Elizabeth A.¹,Windle Bradford E.⁴,Morgan Iain M.⁴,Cohen Roger B.⁷,Gimotty Phyllis A.⁹,Basu Devraj¹¹⁰^ORCID

Affiliation:

1. Department of Otorhinolaryngology The University of Pennsylvania Philadelphia Pennsylvania USA

2. Department of Medicine The University of Chicago Chicago Illinois USA

3. Department of Pathology The University of Pennsylvania Philadelphia Pennsylvania USA

4. School of Dentistry Virginia Commonwealth University Richmond Virginia USA

5. Department of Head and Neck Surgery The MD Anderson Cancer Center Houston Texas USA

6. Department of Radiation Oncology The University of Pennsylvania Philadelphia Pennsylvania USA

7. Department of Medicine The University of Pennsylvania Philadelphia Pennsylvania USA

8. Department of Surgery University of California San Diego San Diego California USA

9. Department of Biostatistics The University of Pennsylvania Philadelphia Pennsylvania USA

10. The Wistar Institute Philadelphia Pennsylvania USA

Funder

National Institute of Dental and Craniofacial Research

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33125

Reference50 articles.

1. Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

2. Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?

3. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

4. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

5. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes;Tumour Virus Research;2024-12

2. The potential of hydrogel‐free tumoroids in head and neck squamous cell carcinoma;Cancer Medicine;2024-08

3. Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models;Molecular Oncology;2024-03

4. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response;Cancers;2023-11-27

5. In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced;Journal of Personalized Medicine;2023-11-03